You are here: Industry Insights > Market News > Brazil regulator gives approval for human trials of J&J COVID-19 vaccine candidate

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate

Neohesperidin

Advantame

Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench

Pharma and Food Grade, USP/FCC Neotame Sweetener E961

Trilobatin

Brazil regulator gives approval for human trials of J&J COVID-19 vaccine candidate

expresspharmaAugust 19, 2020

Tag: COVID-19 vaccine , Johnson & Johnson , ANVISA

Favorites

Brazil’s health regulator Anvisa has approved human clinical trials for a potential COVID-19 vaccine developed by Johnson & Johnson’s pharma subsidiary Janssen.

The Johnson & Johnson vaccine candidate is the fourth to be approved for human trials in Brazil, said Anvisa in a statement.

Brazil has already approved phase 3 human trials of potential vaccines developed by AstraZeneca in partnership with the University of Oxford, China’s Sinovac Biotech and Pfizer in partnership with BioNTech.

China’s Sinopharm also aims to carry out trials for a possible vaccine in Brazil in a deal with the southern state of Parana pending regulatory approval.

Previous:AI accelerates drug repurposing to find potential COVID-19 therapies: GlobalData

Next:D&C Act 1940 should be reframed: Pharma stakeholders

Brazil regulator gives approval for human trials of J&J COVID-19 vaccine candidate

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may like
More>>

Brazil regulator gives approval for human trials of J&J COVID-19 vaccine candidate

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may likeMore>>

You may like
More>>